Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
Medium
Risk
Equity
Other
+
18.42
%
18.42
%
3Y annualised
+
0.34
%
0.34
%
1D
1M
6M
1Y
3Y
All
Fund size
692
NAV:
Mar 7, 2024
26.42
Sector
Tech
Type
Equity
Launched
Jul 2019
Min Investment
1000
Expense Ratio
2
Risk
Medium
Portfolio allocation
Top 10 Holdings
% Value
Sun Pharmaceuticals Industries Ltd
15.09
%
Cipla Ltd
8.31
%
Torrent Pharmaceuticals Ltd
7.5
%
Apollo Hospitals Enterprise Ltd
6.52
%
Sanofi India Ltd
4.33
%
Fortis Healthcare Ltd
4.29
%
Zydus Lifesciences Ltd
4.25
%
Ajanta Pharma Ltd
4.16
%
Lupin Ltd
3.85
%
Alkem Laboratories Ltd
3.69
%
Expense ratio, exit load and tax
Expense Ratio:
2
%
Inclusive of GST
Exit load
Exit load of 1.0% if redeemed within 30.0 Days, 0.0 % if redeemed after 30.0 Days.
Tax implication
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Fund house & investment objective
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
More details
Investment objective
The scheme provides long term capital appreciation by investing in equity/equity
related instruments of the companies in the Pharmaceuticals, Healthcare and Allied
sectors in India.
The Scheme does not guarantee/indicate any returns. There can be no
assurance that the schemes’ objectives will be achieved.
Scheme Information Document
Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator of future returns.
Calculate returns
One-time
Monthly SIP
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
* Returns are calculated as per lifetime average per annum returns of the fund.
Calculate returns
Monthly SIP
One-time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
